New antibacterial mesh aims to cut infection risk in breast reconstruction

NCT ID NCT06027996

Recruiting now Disease control Sponsor: Melodi Health, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a special absorbable mesh that releases antibiotics to help prevent infections in women undergoing two-stage breast reconstruction after mastectomy. About 702 women will be randomly assigned to receive either standard care or the new mesh. The goal is to see if the mesh reduces complications like infection and improves recovery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST RECONSTRUCTION

Contacts and locations

Show contact details

Locations

MD Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States
Mayo Clinic
RECRUITING

Rochester, Minnesota, 55905, United States

Contact Email: •••••@•••••
Medical University of South Carolina
RECRUITING

Charleston, South Carolina, 29425, United States
Monument Health
RECRUITING

Rapid City, South Dakota, 57701, United States
Northwell Health
RECRUITING

Staten Island, New York, 10305, United States
Stanford University
RECRUITING

Palo Alto, California, 94304, United States
The Ohio State University
RECRUITING

Columbus, Ohio, 43212, United States
UPMC
RECRUITING

Pittsburgh, Pennsylvania, 15213, United States
University of Michigan Health
RECRUITING

Ann Arbor, Michigan, 48109, United States
University of Utah
RECRUITING

Salt Lake City, Utah, 84112, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.